Nutra Pharma Corp NPHC Stock Analysis
- OTCCE
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Oct 16
Last close · Previous close $0.00
- 52-week change
- unchangedPrice only
- Distributions
- $0.00Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00unchangedFri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Oct 15
- Volume533.00Oct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume191.09KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.00 to $0.01; now $0.00
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
NPHC beat the S&P 500 in 1 of 7 periods.
| Period | NPHC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | NPHC: unchanged S&P 500: up 1.5% | NPHC trailed the S&P 500 by 1.5 percentage points Trailed |
| 3M | NPHC: down 66.7% S&P 500: up 1.9% | NPHC trailed the S&P 500 by 68.6 percentage points Trailed |
| YTD | NPHC: unchanged S&P 500: up 12.8% | NPHC trailed the S&P 500 by 12.8 percentage points Trailed |
| 1Y | NPHC: unchanged S&P 500: up 16.8% | NPHC trailed the S&P 500 by 16.8 percentage points Trailed |
| Long term | ||
| 3Y | NPHC: up 9,900.0% S&P 500: up 81.5% +364.2% vs +22.0% a year | NPHC beat the S&P 500 by 9,818.5 percentage points Beat |
| 5Y | NPHC: down 96.2% S&P 500: up 83.1% −47.9% vs +12.9% a year | NPHC trailed the S&P 500 by 179.3 percentage points Trailed |
| 10Y | NPHC: down 99.2% S&P 500: up 319.6% −38.4% vs +15.4% a year | NPHC trailed the S&P 500 by 418.8 percentage points Trailed |
$10,000 invested in NPHC 10 years ago (Oct 14, 2016) would be worth about $79 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
NPHC beat the S&P 500 in 1 of 7 periods.
| Period | NPHC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | NPHC: unchanged S&P 500: up 1.2% | NPHC trailed the S&P 500 by 1.2 percentage points Trailed |
| 3M | NPHC: down 66.7% S&P 500: up 1.7% | NPHC trailed the S&P 500 by 68.4 percentage points Trailed |
| YTD | NPHC: unchanged S&P 500: up 11.9% | NPHC trailed the S&P 500 by 11.9 percentage points Trailed |
| 1Y | NPHC: unchanged S&P 500: up 15.5% | NPHC trailed the S&P 500 by 15.5 percentage points Trailed |
| Long term | ||
| 3Y | NPHC: up 9,900.0% S&P 500: up 75.0% +364.2% vs +20.5% a year | NPHC beat the S&P 500 by 9,825.0 percentage points Beat |
| 5Y | NPHC: down 96.2% S&P 500: up 71.2% −47.9% vs +11.4% a year | NPHC trailed the S&P 500 by 167.4 percentage points Trailed |
| 10Y | NPHC: down 99.2% S&P 500: up 258.1% −38.4% vs +13.6% a year | NPHC trailed the S&P 500 by 357.3 percentage points Trailed |
$10,000 invested in NPHC 10 years ago (Oct 14, 2016) would be worth about $79 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$0.24
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Mar 1, 2011.
Stock splits
NPHC hasn’t split since its price history begins in 2011.
About Nutra Pharma Corp
Nutra Pharma Corp. is a biopharmaceutical company engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's products are Cobroxin and Nyloxin/Nyloxin Extra Strength. The wholly owned subsidiaries of the Company are ReceptoPharm, Inc. (ReceptoPharm) and Designer Diagnostics, Inc. (Designer Diagnostics).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Florida, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- OTCCE
- Asset type
- Common stock
- Price history since
NPHC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
NPHC stock FAQ
What is NPHC stock’s price today?
Nutra Pharma (NPHC) traded at $0.00 at the close on , unchanged from the previous close of $0.00. Over the past 52 weeks it has traded between $0.00 and $0.01.
If you invested $1,000 in NPHC 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in NPHC on would be worth about $8 at the close on , a total return of −99.2%. The same $1,000 would be worth $38 if invested five years ago and $1,000 if invested one year ago. Past performance doesn’t predict future returns.
What is Nutra Pharma’s market cap?
Nutra Pharma’s market capitalization is about $402.0 thousand. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.00 (how market cap works).
Does NPHC pay a dividend?
Nutra Pharma hasn’t paid a dividend in the last twelve months.
What is NPHC’s 52-week high and low?
Over the past 52 weeks NPHC has traded as low as $0.00 and as high as $0.01. At $0.00 at the close on , it is 98.0% below that high and 9,900.0% above the low.
What is NPHC’s all-time high?
NPHC’s highest closing price was $0.24 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has NPHC stock ever split?
No. NPHC hasn’t split since its price history begins in 2011.
How has NPHC stock performed?
Including dividends and measured to the close on , NPHC has returned 0.0% so far this year and 0.0% over the past year, and −96.2% over five years (−47.9% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What sector and industry is Nutra Pharma in?
Nutra Pharma is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is headquartered in Florida, USA.
What exchange does NPHC trade on?
Nutra Pharma trades on the OTCCE under the ticker symbol NPHC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.